Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
Stock
ROIV
ROIV News & Events
-
Add to Watchlist
Trade ROIV
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Stock Price Prediction
Technical
Valuation
Financials
Earnings
Should I Buy
News & Events
ROIV News
David Einhorn's Concerns on AI Overvaluation Impacting Stock Picks
20h ago
CNBC
Citi and H.C. Wainwright Raise Roivant Sciences Price Targets Following Positive Drug Data
5d ago
Yahoo Finance
Roivant Sciences (ROIV.US) Officer Plans to Sell $5.3 Million in Common Stock via Form 144
5d ago
moomoo
Top Performing Large-Cap Stocks Last Week
Feb 08 2026
Benzinga
Roivant Sciences Q3 2025 Earnings Call Highlights
Feb 06 2026
seekingalpha
U.S. Markets Increased on Friday; Strategy Reached New Heights
Feb 06 2026
Barron's
Roivant Sciences Stock Soars on Positive Phase 2 Results for Brepocitinib
Feb 06 2026
Benzinga
Molina Healthcare Stock Plummets 29% After Earnings Miss
Feb 06 2026
Benzinga
Show More News
ROIV Events
No data
ROIV Monitor News
Roivant Sciences Stock Soars on Positive Phase 2 Results for Brepocitinib
Feb 09 2026
Roivant Sciences Reports Positive Phase 2 Results for Brepocitinib
Feb 06 2026
Roivant Sciences reaches 5-day high amid market fluctuations
Jan 13 2026
Roivant Sciences Ltd sees stock drop amid market strength
Jan 05 2026
Roivant Sciences Ltd reaches 52-week high amid sector rotation
Dec 16 2025
Roivant Sciences outlines accelerated timelines for key drug developments
Dec 12 2025
Roivant Sciences Ltd reaches a 52-week high amid sector rotation.
Dec 11 2025
ROIV Earnings Analysis
Roivant Sciences Earnings & Drug Discoveries Update- Intellectia AI™
3 months ago
Roivant Sciences Shows Resilience with Strategic Advancements - Intellectia AI™
1 years ago
Roivant Reports Second Quarter Financial Results for 2024
1 years ago
People Also Watch
